| abstract |
The present invention relates to a platinum-based agent (e.g., carboplatin) in combination with an antibody-drug conjugate (e.g., thisotumab vedotin) that binds to tissue factor (TF), and cancer, such as bladder cancer and uterus It provides its use in a method of treating cervical cancer. The present invention also provides platinum-based agents (e.g., carboplatin) and antibody-drug conjugates that bind TF (e.g., thisotumab vedotin) for use in treating cancer, such as bladder cancer and cervical cancer. It provides a composition and kit comprising a. |